Finished
Robotic Versus Laparoscopic Right Hemicolectomy With Complete Mesocolic Excision
NCT05457426 · Third Military Medical University · Updated 21 July 2022
- What is being tested
- robotic right hemicolectomy with CME
- For
- Perioperative Outcomes; Oncological Outcomes
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 382 people. The full rules are on the registry page.
- Where
- China (3 sites)
- When
- Starts or started 1 April 2022, ends 22 June 2022. Registered 14 July 2022.
- Results
- None posted yet.
In the researchers' words
the investigators performed a retrospective multicenter propensity score matching study. From July 2016 to July 2021, 382 consecutive patients from different Chinese surgical departments were available for inclusion out of an initial cohort of 412, who underwent robotic or laparoscopic right hemicolectomy with CME.
Sites
- Chongqing University Three Gorges HospitalWanzhou, Chongqing Municipality, China
- Army Medical CenterYuzhong, Chongqing Municipality, China
- No. 940 Hospital of Joint Logistics Support Foce of Chinese People's Liberation ArmyLanzhou, Gansu, China